PHATHOM PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
PHATHOM PHARMACEUTICALS, INC. (PHAT) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $13.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-02-26
- PHATHOM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $13.00K.
- PHATHOM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was -$212.00K, a 270.97% decline from fiscal 2022.
- PHATHOM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $124.00K.
- PHATHOM PHARMACEUTICALS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was -$4.00K.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $13.00K 10-K · filed 2026-02-26 | |
| 2023-12-31 | -$212.00K 10-K · filed 2025-03-06 | $212.00K 10-K · filed 2024-03-07 |
| 2022-12-31 | $124.00K 10-K/A · filed 2024-06-14 | $125.00K 10-K · filed 2023-02-28 |
| 2021-12-31 | -$4.00K 10-K · filed 2023-02-28 | |
| 2020-12-31 | -$68.00K 10-K · filed 2022-03-01 | |
| 2019-12-31 | $55.00K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |